Pulmonary arterial hypertension, Who group 1 (see Pulmonary hypertension#Causes), in humans in commonly treated with specific pulmonary artery vasodilators that increase survival such as the prostacyclin I2 (PGI2) mimetics including Treprostinil, epoprostanol, Iloprost, and beraprost.
Pulmonary arterial hypertension, a common condition in humans, is often treated with targeted medications that improve survival rates. These treatments include specific pulmonary artery relaxants such as the prostacyclin I2 (PGI2) mimetics Treprostinil, epoprostanol, Iloprost, and beraprost.